Digital Health-Driven Heart Failure Program

ESC Immediate Past-President (2018 – 2020), Jeroen Bax is Director of non-invasive imaging and Director of the echo-lab at the Leiden University Medical Center. His main interests include clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields. Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations, as well as serving on the editorial boards of many different journals.

Works at Vanderbilt University, Nashville, TN. Features in 1 video on Wondr Medical. JoAnn Lindenfeld generally speaks on PFO/ASD.

Partho Senguptha is a professor of cardiology at West Virginia University Heart and Vascular Institute, Morgantown, WV, US.

Dr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 550 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program. Peter has been principle/founder of twenty-one medical device companies in the San Francisco Bay Area. Fourteen of these have been transitioned to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2009, he co-founded TriVentures in Israel & Silicon Valley, which is a venture fund focused on early-mid stage medical technology and digital healthcare.

Prof. Stefan Anker is Professor of Tissue Homeostasis in Cardiology & Metabolism at Charité Berlin. Previously, he was Professor of Innovative Clinical Trials at University Medical Center Göttingen in Germany. Dr. Anker has authored more than 1,000 articles and was named Highly Cited Researcher 2015–2020.